Reference is made to the stock exchange announcement byBerGenBio ASA ("BerGenBio ") on16 April 2024 regarding the final results of the last exercise period for the warrants issued in connection with the rights issue inBerGenBio inJune 2023 .Meteva AS has exercised 175,298,805 warrants and has therefore today been allocated 175,298,805 new shares inBerGenBio . Following issuance of the new sharesMeteva AS will hold 880,114,786 shares and votes inBerGenBio , representing approx. 23.19% of the shares and votes outstanding inBerGenBio . This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source